INNATE PHARMA (EPA:IPH) Innate Pharma (Euronext Paris : FR0010331421 – IPH) swaps products with Novo Nordisk A/S to obtain full commercial rights for IPH 2101, a monoclonal antibody in Phase I cancer clinical trials
Transparency directive : regulatory news
06/10/2008 17:51
source : webdisclosure.com
INNATE PHARMA's latest news
17/06/2024 07:00
23/05/2024 22:00
05/04/2024 09:34
19/03/2024 07:00
21/02/2024 07:00
03/11/2023 07:00
29/08/2023 07:00
10/08/2023 07:00
10/06/2023 07:00
12/05/2023 22:00
Other stories
31/10/2024 18:50
31/10/2024 21:54
31/10/2024 14:21
31/10/2024 22:47
31/10/2024 20:31
31/10/2024 20:35
31/10/2024 21:32
31/10/2024 21:37
31/10/2024 15:51
31/10/2024 22:59
31/10/2024 22:53
31/10/2024 23:25
31/10/2024 20:16
31/10/2024 14:04
01/11/2024 00:09
31/10/2024 18:49
31/10/2024 12:44
31/10/2024 13:18
31/10/2024 17:50
31/10/2024 18:50
31/10/2024 17:48
31/10/2024 07:27
01/11/2024 00:18
31/10/2024 22:38
31/10/2024 20:55
Has Nish left EastEnders? Dramatic exit sees actor Navin Chowdhry leave after two years - The Mirror
31/10/2024 20:38
01/11/2024 01:10
31/10/2024 19:29
31/10/2024 22:00
31/10/2024 20:07
31/10/2024 13:43
31/10/2024 12:15
31/10/2024 08:40
31/10/2024 19:52
31/10/2024 11:44
30/10/2024 16:00
31/10/2024 20:56
31/10/2024 08:16